FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

8 letters match. Newest first.

  1. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  2. InVia Fertility Specialists, PLLC

    FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.

    High risk
  3. Sperm Bank, Inc. dba Fertility Center of California

    FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.

    High risk
  4. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  5. Washington Fertility Center

    FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.

    High risk
  6. The New Hope Center for Reproductive Medicine

    FDA warns Virginia Beach fertility center over incomplete donor screening and testing for reproductive tissue.

    High risk
  7. Cryos International USA LLC

    Cryos International USA released and distributed anonymous donor semen without required infectious disease testing and quarantine.

    High risk
  8. Cooper Institute

    FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.

    High risk